mRNA |
BRD-A94377914 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0003 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0004 |
mRNA |
GMX-1778 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0004 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0004 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0004 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0004 |
mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.0005 |
mRNA |
BRD-K09587429 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0005 |
mRNA |
thapsigargin |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0005 |
mRNA |
NSC95397 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0006 |